ICU Medical (ICUI) stock soared 13.36% in pre-market trading on Friday, following a significant price target upgrade from Piper Sandler. The healthcare company's shares received a boost after the investment firm raised its target price for ICU Medical from $153 to $172.

Piper Sandler's decision to increase the price target suggests growing confidence in ICU Medical's future performance and potential. The firm maintained its Overweight rating on the stock, indicating a positive outlook for the company. This upgrade comes amid a series of analyst actions in the healthcare sector, reflecting broader market sentiment towards healthcare stocks.

While specific reasons for the upgrade were not detailed in the available news, investors seem to be responding positively to the analyst's more optimistic valuation. The pre-market surge indicates that market participants are reevaluating ICU Medical's prospects in light of this bullish analyst view. As trading opens, it will be interesting to see if the stock can maintain this momentum and if other analysts follow suit with revised outlooks for ICU Medical.